Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift
- Avantor Inc AVTR on Friday reported adjusted EPS of 23 cents in line with consensus.
- 04/25/2025
|
Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut
- Avantor (AVTR) shares sank 16% Friday after the maker of lab chemicals and other life sciences products announced its CEO was resigning, reported weaker-than-expected net sales as government spending fell, and slashed its guidance.
- 04/25/2025
|
Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q1 2025 Earnings Call April 25, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications and Brand Michael Stubblefield - President and CEO R. Brent Jones - EVP and CFO Conference Call Participants Michael Ryskin - Bank of America Securities Vijay Kumar - Evercore ISI Rachel Vatnsdal - J.P.
- 04/25/2025
|
Compared to Estimates, Avantor (AVTR) Q1 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Avantor (AVTR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 04/25/2025
|
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates
- Avantor, Inc. (AVTR) came out with quarterly earnings of $0.23 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago.
- 04/25/2025
|
Avantor® Announces CEO Transition
- Board initiates search process to identify next CEO RADNOR, Pa. , April 25, 2025 /PRNewswire/ -- Avantor, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, today announced that Michael Stubblefield intends to step down from his role as Director, President and Chief Executive Officer upon the appointment of a successor.
- 04/25/2025
|
Avantor® Reports First Quarter 2025 Results
- Net sales of $1.58 billion, decrease of 6%; organic decline of 2% Net income of $64.5 million; Adjusted EBITDA of $269.5 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.23 Operating cash flow of $109.3 million; free cash flow of $82.1 million Announces significant actions across the business to accelerate growth and enhance cost structure; increasing cost transformation target to $400 million in gross run-rate savings exiting 2027 RADNOR, Pa. , April 25, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2025.
- 04/25/2025
|
Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX
- Industry leading set of technologies to drive scalability, flexibility, and efficiency in biologics production RADNOR, Pa. , April 1, 2025 /PRNewswire/ -- Avantor®, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, announces its presence at INTERPHEX, the premier annual gathering of pharmaceutical, biotechnology, and device development and manufacturing professionals.
- 04/01/2025
|
Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025
- RADNOR, Pa. , March 28, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2025 financial results before the market opens on Friday, April 25, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
- 03/28/2025
|
Here's Why You Should Hold AVTR Stock in Your Portfolio for Now
- Avantor is set for growth with a strong portfolio and solid fourth quarter results, but challenges like customer losses and forex volatility pose potential risks.
- 03/27/2025
|
Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025
- Facility in Gliwice, Poland to boost biopharma manufacturers' efficiency and speed to market of therapies RADNOR, Pa. , March 17, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology industries, announces that Ger Brophy, PhD, head of Avantor's Scientific Advisory Board, will present highlights of the recently completed expansion at its flagship European manufacturing site at Drug, Chemical & Associated Technologies Association (DCAT) Week 2025.
- 03/17/2025
|
Avantor® to Present at TD Cowen's 45th Annual Health Care Conference
- RADNOR, Pa. , Feb. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will present at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, at 11:50 a.m.
- 02/19/2025
|
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology
- SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE: AVTR), and a leading global supplier of high-quality silicones for long-term medical implants, have entered into an agreement to facilitate the utilization of Silq's zwitterionic surface treatment technology on medical devices manufactured with NuSil silicone products. Zwitterion surface technolog.
- 02/19/2025
|
Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand
- Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.
- 02/10/2025
|
Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent Jones - EVP and CFO Conference Call Participants Vijay Kumar - Evercore ISI Michael Ryskin - Bank of America Daniel Brennan - TD Cowen Rachel Vatnsdal - JP Morgan Tycho Peterson - Jefferies Luke Sergott - Barclays Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Conor McNamara - RBC Capital Markets Ivy Ma - Goldman Sachs Brandon Couillard - Wells Fargo Jack Meehan - Nephron Research Operator Hello everybody and a warm welcome to Avantor's Fourth Quarter 2024 Earnings Call. My name is Emily and I'll be coordinating your call today.
- 02/07/2025
|
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/07/2025
|
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
- On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion.
- 02/07/2025
|
Avantor, Inc. (AVTR) Surpasses Q4 Earnings Estimates
- Avantor, Inc. (AVTR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.
- 02/07/2025
|
Avantor® Reports Fourth Quarter and Full Year 2024 Results
- Fourth Quarter 2024 Net sales of $1.69 billion, decrease of 2%; organic growth of 1% Net income of $500.4 million; Adjusted EBITDA of $307.7 million Diluted GAAP EPS of $0.73; adjusted EPS of $0.27 Operating cash flow of $173.3 million; free cash flow of $222.1 million Full Year 2024 Net sales of $6.78 billion, decrease of 3%; organic decline of 2% Net income of $711.5 million; Adjusted EBITDA of $1,198.8 million Diluted GAAP EPS of $1.04; adjusted EPS of $0.99 Operating cash flow of $840.8 million; free cash flow of $768.3 million RADNOR, Pa. , Feb. 7, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its fourth fiscal quarter and year ended December 31, 2024.
- 02/07/2025
|
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
- SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, to expand availability of its innovative nucleic acid products to customers across Europe, Middle East, and Africa (EMEA). This distribution pa.
- 02/03/2025
|
MD vs. AVTR: Which Stock Is the Better Value Option?
- Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
- 01/13/2025
|
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
- RADNOR, Pa. , Jan. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Friday, February 7, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
- 01/10/2025
|
Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- RADNOR, Pa. , Jan. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will present at the 43rd Annual J.P.
- 01/03/2025
|
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
- Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
- 12/27/2024
|
Avantor: Durable FCF Generator Trading For Cheap
- Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor's leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansion. Significant FCF generation can improve the company's capital structure and return value to shareholders.
- 12/18/2024
|
MD or AVTR: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
- 12/11/2024
|
MD or AVTR: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
- 11/25/2024
|
Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
- RADNOR, Pa. , Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Tuesday, December 3, at 9:10 a.m.
- 11/20/2024
|
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
- BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio, providing researchers across all market segments in t.
- 11/20/2024
|
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
- RADNOR, Pa. , Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new flagship Bridgewater Innovation Center.
- 11/14/2024
|
MD vs. AVTR: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
- 11/07/2024
|
Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
- RADNOR, Pa. , Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D.
- 11/06/2024
|
Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
- Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.
- 10/28/2024
|
Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript
- Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Douglas Schenkel - Wolfe Research Tycho Peterson - Jefferies Michael Ryskin - Bank of America Vijay Kumar - Evercore ISI Daniel Leonard - UBS Conor McNamara - RBC Capital Markets Daniel Arias - Stifel Rachel Vatnsdal - JP Morgan Luke Sergott - Barclays Tejas Savant - Morgan Stanley Operator Good morning. My name is Emily, and I will be your conference operator today.
- 10/25/2024
|
Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 10/25/2024
|
Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
- Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.
- 10/25/2024
|
Avantor® Reports Third Quarter 2024 Results
- Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 million Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 Operating cash flow of $244.8 million; free cash flow of $204.0 million RADNOR, Pa. , Oct. 25, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its third fiscal quarter ended September 30, 2024.
- 10/25/2024
|
Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
- Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing RADNOR, Pa. , Oct. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced an expanded partnership with the National Institute for Bioprocessing Research and Training (NIBRT).
- 10/23/2024
|
AVTR Stock Flat Following the Close of Divestiture Deal With Audax
- Avantor closes its deal with Audax to divest its clinical services business.
- 10/21/2024
|
Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions
- SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) has completed its acquisition of the clinical services business of Avantor, Inc. (NYSE: AVTR) and, in close collaboration with the employees, has re-branded the business as Resonant Clinical Solutions (“Resonant” or “the Company”). Resonant is comprised of three well-respected brands – EPL Archives, MESM, and Therapak. These long-standing brands, whose roots and lineage extend as far back as the 1970s, provide a comprehensi.
- 10/18/2024
|
Avantor® Closes Previously Announced Divestiture of its Clinical Services Business
- RADNOR, Pa. , Oct. 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to Audax Private Equity in a transaction valued at approximately $650 million.
- 10/18/2024
|
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
- Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
- 10/02/2024
|
Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management
- Recognition highlights commitment to Avantor Business System (ABS) principles to enhance customer experience RADNOR, Pa. , Sept. 30, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced today that the Company's NuSil brand has received the 2024 North American Daily Kaizen Management award from the Kaizen Institute.
- 09/30/2024
|
Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024
- RADNOR, Pa. , Sept. 27, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2024 financial results before the market opens on Friday, October 25, and will hold a conference call on the same day at 8:00 a.m.
- 09/27/2024
|
Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement
- Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy annually beginning in 2026 Avantor continues to implement global solar installations, with more planned in 2025 RADNOR, Pa. , Sept. 25, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, has entered into a 10-year virtual power purchase agreement through the Energize program, a first of its kind initiative to increase access to renewable energy for pharmaceutical supply chains.
- 09/25/2024
|
Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition
- RADNOR, Pa. , Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at BioProcess International 2024, scheduled for September 23-26 in Boston.
- 09/23/2024
|
Broyhill's Q2 2024 Top Five Investments
- Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in July after a strong earnings report, reaffirming full-year guidance and showing signs of industry recovery. Baxter's shares increased significantly post-earnings, demonstrating portfolio durability and organic growth, prompting us to accumulate shares at attractive valuations.
- 09/13/2024
|
Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance
- EcoVadis Rating validates Avantor's business sustainability commitments and performance RADNOR, Pa. , Sept. 12, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced today, for the second year in a row, that the Company has been awarded a Bronze Medal from EcoVadis, a global leader in business sustainability assessments.
- 09/12/2024
|
Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- RADNOR, Pa. , Aug. 22, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5, at approximately 10:45 a.m.
- 08/22/2024
|
Avantor (AVTR) Inks Deal to Optimize Portfolio, Reduce Debt
- Avantor's (AVTR) latest agreement is likely to enhance its focus on strategic growth opportunities and reduce its debt burden.
- 08/19/2024
|
Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private Equity
- Accelerates ongoing business transformation and sharpens Avantor's strategic focus Strengthens balance sheet with proceeds to be used for debt paydown RADNOR, Pa. , Aug. 16, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the signing of a definitive agreement to divest its clinical services business, including kitting, biorepository, and related equipment and ancillaries (collectively "Clinical Services"), to Audax Private Equity ("Audax") for a transaction value of approximately $650 million.
- 08/16/2024
|
Avantor's (AVTR) Q2 Earnings Beat, Operating Margin Declines
- Avantor's (AVTR) revenues decline in the second quarter with new segmental changes. Bioprocessing orders decline.
- 07/29/2024
|
Avantor Analysts Increase Their Forecasts After Better-Than-Expected Earnings
- Avantor, Inc. AVTR reported better-than-expected second-quarter earnings results on Friday.
- 07/29/2024
|
Avantor, Inc. (AVTR) Q2 Earnings and Revenues Beat Estimates
- Avantor, Inc. (AVTR) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.28 per share a year ago.
- 07/26/2024
|
Avantor® Reports Second Quarter 2024 Results
- Net sales of $1.70 billion, decrease of 2.4%; organic decline of 2.0% Net income of $93 million; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14; adjusted EPS of $0.25 Operating cash flow of $281 million; free cash flow of $235 million RADNOR, Pa. , July 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its second fiscal quarter ended June 30, 2024.
- 07/26/2024
|
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
- NEW YORK , July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp. (NASD:QDEL) in the S&P MidCap 400, and QuidelOrtho will replace Hibbett Inc. (NASD:HIBB) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 26. JD Sports Fashion Plc (XLON: JD) is acquiring Hibbett in a deal expected to close soon pending final closing conditions.
- 07/23/2024
|
Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for
- Avantor (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/19/2024
|
3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now
- Avantor's (AVTR) strong product portfolio raises optimism about the stock.
- 07/10/2024
|
Avantor (AVTR) Launches Solutions for Gene Therapy Harvest
- Avantor, Inc. AVTR recently released two innovative products aimed at revolutionizing the gene therapy harvest process. J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease are designed to enhance efficiency, reduce environmental impact, improve operational outcomes and preserve the integrity of viral particles.
- 07/02/2024
|
Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease
- Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at Scale RADNOR, Pa. , July 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease.
- 07/01/2024
|
Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024
- RADNOR, Pa. , June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2024 financial results before the market opens on Friday, July 26, and will hold a conference call on the same day at 8:00 a.m.
- 06/28/2024
|
Avantor® Appoints Corey Walker as President of Laboratory Solutions
- RADNOR, Pa. , June 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Corey Walker has rejoined the company as President of Avantor's Laboratory Solutions business, reporting to CEO Michael Stubblefield.
- 06/21/2024
|
Avantor® Releases 2024 Science for Goodness Sustainability Report
- Achieves 2025 Greenhouse Gas Emission reduction goals two years ahead of schedule RADNOR, Pa., June 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, released its 2024 Sustainability Report today.
- 06/18/2024
|
Reasons Why You Should Retain Avantor (AVTR) Stock for Now
- Avantor's (AVTR) strong product portfolio raises optimism about the stock.
- 05/30/2024
|
Avantor® to Participate in Goldman Sachs Global Healthcare Conference
- RADNOR, Pa. , May 29, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Fla.
- 05/29/2024
|
Avantor® to Participate in Bernstein's 40th Annual Strategic Decisions Conference
- RADNOR, Pa. , May 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at Bernstein's 40th Annual Strategic Decisions Conference in New York on Thursday, May 30, 2024 at approximately 8:00 a.m.
- 05/21/2024
|
Avantor® to Participate in BofA Securities 2024 Health Care Conference
- RADNOR, Pa. , May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m.
- 05/03/2024
|
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
- Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.
- 04/29/2024
|
Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript
- Avantor Inc. (NYSE:AVTR ) Q1 2024 Earnings Conference Call April 26, 2024 8:00 AM ET Company Participants Christina Jones – Vice President-Investor Relations Michael Stubblefield – President and Chief Executive Officer Brent Jones – Executive Vice President and Chief Financial Officer Conference Call Participants Michael Ryskin – Bank of America Dan Leonard – UBS Dan Brennan – TD Cowen Luke Sergott – Barclays Vijay Kumar – Evercore ISI Jack Meehan – Nephron Research Doug Schenkel – Wolfe Research Rachel Vatnsdal – JPMorgan Tejas Savant – Morgan Stanley Josh Waldman – Cleveland Research Patrick Donnelly – Citi Operator Good morning. My name is Emily, and I'll be your conference operator today.
- 04/26/2024
|
Avantor® Reports First Quarter 2024 Results
- Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% Net income of $60 million; Adjusted EBITDA of $283 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 Operating cash flow of $142 million; free cash flow of $107 million RADNOR, Pa. , April 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2024.
- 04/26/2024
|
Is a Surprise Coming for Avantor (AVTR) This Earnings Season?
- Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/25/2024
|
ELV or AVTR: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
- 04/25/2024
|
Stay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat
- Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.
- 04/25/2024
|
BLCO vs. AVTR: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
- 04/08/2024
|
Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024
- RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m.
- 04/01/2024
|
Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio
- Avantor's (AVTR) strong product portfolio raises optimism about the stock.
- 03/26/2024
|
BLCO or AVTR: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
- 03/21/2024
|
BLCO or AVTR: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical Services sector might want to consider either Bausch + Lomb (BLCO) or Avantor, Inc. (AVTR). But which of these two stocks presents investors with the better value opportunity right now?
- 03/21/2024
|
Avantor® Celebrates Supplier Award Honorees at 2024 European Sales Conference
- RADNOR, Pa. and LISBON, Portugal , Feb. 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, recognized supplier excellence across a range of categories and products at its 2024 European Sales Conference in Lisbon, Portugal earlier this month.
- 02/26/2024
|
New Strong Sell Stocks for February 20th
- HAFC, AVTR and WHD have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.
- 02/20/2024
|
Avantor® to Participate in the 44th Annual TD Cowen Health Care Conference
- RADNOR, Pa. , Feb. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m.
- 02/20/2024
|
Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down
- Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.
- 02/15/2024
|
Avantor, Inc. (AVTR) Q4 2023 Earnings Call Transcript
- Avantor, Inc. (AVTR) Q4 2023 Earnings Call Transcript
- 02/14/2024
|
Compared to Estimates, Avantor, Inc. (AVTR) Q4 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/14/2024
|
Avantor® Reports Fourth Quarter and Full Year 2023 Results
- Fourth Quarter 2023 Net sales of $1.72 billion, decrease of 4.0%; core organic decline of 4.8% Net income of $98.5 million; Adjusted EBITDA of $302.1 million Diluted GAAP EPS of $0.15; adjusted EPS of $0.25 Operating cash flow of $251.6 million; free cash flow of $201.0 million Full Year 2023 Net sales of $6.97 billion, decrease of 7.3%; core organic decline of 5.2% Net income of $321.1 million; Adjusted EBITDA of $1,309.1 million Diluted GAAP EPS of $0.47; adjusted EPS of $1.06 Operating cash flow of $870.0 million; free cash flow of $723.6 million Adjusted net leverage of 3.9X; repaid approximately $850 million of debt in 2023 RADNOR, Pa. , Feb. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for the fourth quarter and year ended December 31, 2023.
- 02/14/2024
|
Curious about Avantor, Inc. (AVTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Avantor, Inc. (AVTR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
- 02/09/2024
|
ELV vs. AVTR: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
- 02/02/2024
|
Avantor® to Report Fourth Quarter and Full Year 2023 Earnings on Wednesday, February 14, 2024
- RADNOR, Pa. , Jan. 24, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February, 14, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
- 01/24/2024
|
Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite
- Avantor's (AVTR) latest offerings are likely to provide its customers with products, materials and services that would aid in accelerating therapeutics.
- 11/15/2023
|
Compared to Estimates, Avantor, Inc. (AVTR) Q3 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 10/27/2023
|
Avantor, Inc. (AVTR) Q3 2023 Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President & CEO Brent Jones - EVP & CFO Conference Call Participants Daniel Brennan - TD Cowen Vijay Kumar - Evercore ISI Jack Meehan - Nephron Research Michael Ryskin - Bank of America Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Luke Sergott - Barclays Daniel Leonard - UBS Catherine Schulte - Robert W. Baird Operator Good morning.
- 10/27/2023
|
Avantor, Inc. (AVTR) Q3 Earnings Meet Estimates
- Avantor, Inc. (AVTR) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.34 per share a year ago.
- 10/27/2023
|
Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for
- Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/20/2023
|
Avantor® to Host Third Quarter 2023 Earnings Call on Friday, October 27, 2023
- RADNOR, Pa. , Sept. 29, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, will release its third quarter 2023 financial results before the market opens on Friday, October 27, and will hold a conference call on the same day at 8:00 a.m.
- 09/29/2023
|
Robert Olstein's Olstein Funds 2023 Annual Letter
- August 9, 2023
- 09/11/2023
|
Avantor's (AVTR) Tie-Up to Address Temperature-Specific Logistics
- Avantor's (AVTR) partnership is likely to meet the growing need among biopharma and life science companies for end-to-end solutions.
- 09/11/2023
|
New Strong Sell Stocks for September 11th
- AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.
- 09/11/2023
|
Avantor® to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
- RADNOR, Pa. , Aug. 29, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York on Tuesday, September 12, at approximately 8:10 a.m.
- 08/29/2023
|
New Strong Sell Stocks for August 22nd
- AVTR, BHLB and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2023.
- 08/22/2023
|
Avantor (AVTR) Q2 Earnings Lag Estimates, FY23 View Revised
- Despite Avantor's (AVTR) strength in end markets, it reports an overall soft second-quarter performance.
- 07/31/2023
|
Avantor, Inc. (AVTR) Q2 2023 Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q2 2023 Earnings Conference Call July 28, 2023 8:00 AM ET Company Participants Christina Jones - Vice President, Investor Relations Michael Stubblefield - President & Chief Executive Officer Tom Szlosek - Executive Vice President & Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Michael Ryskin - Bank of America Luke Sergott - Barclays Vijay Kumar - Evercore ISI Rachel Vatnsdal - JPMorgan Matt Sykes - Goldman Sachs Patrick Donnelly - Citi Justin Bowers - Deutsche Bank Operator Good morning. My name is Emily and I'll be your conference operator today.
- 07/28/2023
|
Here's What Key Metrics Tell Us About Avantor, Inc. (AVTR) Q2 Earnings
- While the top- and bottom-line numbers for Avantor, Inc. (AVTR) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 07/28/2023
|
Avantor shares fall after ‘challenging' biopharma market hurts second quarter results
- Shares of Avantor Inc. AVTR, -2.14% fell 4% premarket on Friday after the company, a provider of lab equipment and services for the biopharma, healthcare and other industries, reported second quarter earnings below analysts' estimates. Market trends, particularly in biopharma, “were more challenging than anticipated” during the quarter, CEO Michael Stubblefield said in a statement.
- 07/28/2023
|
Avantor, Inc. (AVTR) Misses Q2 Earnings and Revenue Estimates
- Avantor, Inc. (AVTR) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.37 per share a year ago.
- 07/28/2023
|
Avantor, Inc. (AVTR) Soars 6.7%: Is Further Upside Left in the Stock?
- Avantor, Inc. (AVTR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 07/24/2023
|
Avantor's (AVTR) New Expansion Plans to Boost Workflow
- Avantor's (AVTR) latest expansion plans are likely to aid customers in creating customized workflow solutions.
- 07/20/2023
|
Avantor® to Host Second Quarter 2023 Earnings Call on Friday, July 28, 2023
- RADNOR, Pa. , June 29, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that it will release its second quarter 2023 financial results before the market opens on Friday, July 28, and will hold a conference call on the same day at 8:00 a.m.
- 06/29/2023
|
Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry
- Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry
- 06/28/2023
|
Avantor's (AVTR) New Tie-Up to Improve Lab Inventory Management
- Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.
- 05/23/2023
|
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
- Despite Avantor's (AVTR) strength in bioproduction and strength in Applied Technologies and Advanced Materials end markets, it reports an overall soft Q1 performance.
- 05/02/2023
|
Avantor, Inc. (AVTR) Q1 2023 Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q1 2023 Earnings Conference Call April 28, 2023 8:00 AM ET Company Participants Christina Jones - Vice President of Investor Relations Michael Stubblefield - President and Chief Executive Officer Thomas Szlosek - Executive Vice President and Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Patrick Donnelly - Citi Michael Ryskin - Bank of America Rachel Vatnsdal - JPMorgan Dan Brennan - TD Cowen Jack Meehan - Nephron Research Dan Arias - Stifel John Sourbeer - UBS Operator Good morning. My name is Emily, and I will be your conference operator today.
- 04/28/2023
|
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Beat Estimates
- Avantor, Inc. (AVTR) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.38 per share a year ago.
- 04/28/2023
|
Avantor® to Host First Quarter 2023 Earnings Call on Friday, April 28, 2023
- RADNOR, Pa. , April 4, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that it will release its first quarter 2023 financial results before the market opens on Friday, April 28, and will hold a conference call on the same day at 8:00 a.m.
- 04/04/2023
|
Here's Why You Should Retain Avantor (AVTR) Stock for Now
- Investors continue to be optimistic about Avantor's (AVTR) strong product portfolio.
- 03/28/2023
|
Avantor, Inc. (AVTR) Q4 2022 Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q4 2022 Earnings Conference Call February 3, 2023 8:00 AM ET Company Participants Christina Jones - Vice President of Investor Relations Michael Stubblefield - President and Chief Executive Officer Thomas Szlosek - Executive Vice President and Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Luke Sergott - Barclays Vijay Kumar - Evercore ISI Michael Ryskin - Bank of America Dan Brennan - Cowen Tejas Sevant - Morgan Stanley Dan Leonard - Credit Suisse Brandon Couillard - Jefferies Josh Waldman - Cleveland Research Operator Good morning. My name is Emily, and I will be your conference operator today.
- 02/03/2023
|
Avantor, Inc. (AVTR) Q4 Earnings and Revenues Top Estimates
- Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 6.67% and 0.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/03/2023
|
Avantor: Re-Rating To Buy, Paying Fair Price At 17x Forward P/E (Rating Upgrade)
- Avantor endured a heavy selloff across FY22, but has since bounced off 52-week lows. The selloff was justified, however, as its return on invested capital fell below the WACC hurdle during this time.
- 01/28/2023
|
Avantor® to Report Fourth Quarter and Full Year 2022 Earnings and Host Earnings Call on Friday, February 3, 2023
- RADNOR, Pa. , Jan. 6, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its fourth quarter and full year 2022 financial results before the market opens on Friday, February 3, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
- 01/06/2023
|
Final Trades: Kohl's, Schwab & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/30/2022
|
5 Stocks Gurus and Insiders Are Building Positions In
- According to the Double Buys Screener, a Premium feature of GuruFocus, five stocks with high guru and insider buys over the past few months include Intel Corp. ( INTC , Financial), Neogen Corp. ( NEOG , Financial), Kyndryl Holdings Inc. ( KD , Financial), Avantor Inc. ( AVTR , Financial) and Macerich Co. ( MAC , Financial).
- 12/06/2022
|
Avantor: Reduce To Hold, Awaiting Convergence Of Price, Fundamentals
- Avantor, Inc. has re-rated heavily to the downside amid a vigorous selloff throughout FY22. Shares now have drifted past 2-year lows and more downside could arrive before Avantor finds a bottom.
- 11/10/2022
|
These Were The Five Best And Worst Performing Basic Materials Stocks In October 2022
- Basic materials, such as metal, concrete and chemicals, form the backbone of the global economy because every sector requires basic materials.
- 11/04/2022
|
Avantor (AVTR) Q3 Earnings Top Estimates, 2022 EPS View Cut
- Avantor's (AVTR) robust performance across the majority of its segments drives its Q3 sales, despite business challenges.
- 10/31/2022
|
Avantor, Inc. (AVTR) Q3 2022 Results - Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q3 2022 Results Earnings Conference Call October 28, 2022 8:00 AM ET Company Participants Christina Jones - Vice President of Investor Relations Michael Stubblefield - President and Chief Executive Officer Thomas Szlosek - Executive Vice President and Chief Financial Officer Conference Call Participants Derik de Bruin - Bank of America Securities Vijay Kumar - Evercore ISI Tejas Sevant - Morgan Stanley Brandon Couillard - Jefferies Dan Arias - Stifel Dan Brennan - Cowen Jack Meehan - Nephron Research John Sourbeer - UBS Tim Daley - Wells Fargo Andrew Cooper - Raymond James Matthew Sykes - Goldman Sachs Operator Good morning. My name is Harry and I will be your conference operator today.
- 10/28/2022
|
Avantor, Inc. (AVTR) Q3 Earnings and Revenues Top Estimates
- Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 3.03% and 0.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2022
|
Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022
- RADNOR, Pa. , Sept. 29, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its third quarter 2022 financial results before the market opens on Friday, October 28, and will hold a conference call on the same day at 8:00 a.m.
- 09/29/2022
|
U.S. Market Faces Worst Meltdown Since 2020: Here's Why
- Major U.S. indices nosedived on Sep 14 following the inflation report for the month of August.
- 09/14/2022
|
Avantor (AVTR) Stock: Why It Fell 8.87% Today
- The stock price of Avantor (AVTR) fell by 8.87% today. This is why.
- 09/13/2022
|
Avantor® to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
- RADNOR, Pa. , Aug. 30, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Monday, September 12, at approximately 4:15 p.m.
- 08/30/2022
|
Avantor's (AVTR) Stock Falls 8.8% Since Q2 Earnings Miss
- Avantor's (AVTR) robust performance across majority of its segments drives its Q2 sales, despite business challenges.
- 08/02/2022
|
Avantor: Portfolio Resiliency With This Long-Term Cash Compounder
- Avantor continues to exhibit resilient characteristics that look increasingly attractive in the current investment landscape. Sustained return on investment and ongoing FCF conversion with a ~4.3% 3-year normalized FCF yield exemplify this.
- 08/01/2022
|
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q2 2022 Results - Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q2 2022 Earnings Conference Call July 29, 2022 8:00 AM ET Company Participants Christina Jones - Vice President of Investor Relations Michael Stubblefield - President, Chief Executive Officer & Director Thomas Szlosek - Executive Vice President & Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore Dan Brennan - Cowen Luke Sergott - Barclays Rachel Vatnsdal - JPMorgan Tejas Savant - Morgan Stanley Matt Sykes - Goldman Sachs Paul Knight - KeyBanc Jack Meehan - Nephron Research Michael Ryskin - Bank of America Patrick Donnelly - Citi Operator Good morning, ladies and gentlemen. My name is Irene and I will be your conference operator today.
- 07/29/2022
|
Why Avantor Stock Crashed 10% Today
- The chemicals company missed analysts' expectations for earnings last night.
- 07/29/2022
|
3 Stocks With High Ebitda Margins
- If you want to have a higher chance of finding companies that are in good shape from a financial standpoint, you may want to consider stocks with trailing 12-month Ebitda margins that are topping the S&P 500's 14.3% as of the time of writing.
- 07/28/2022
|
AVTR or DOCS: Which Is the Better Value Stock Right Now?
- AVTR vs. DOCS: Which Stock Is the Better Value Option?
- 07/15/2022
|
Avantor® to Host Second Quarter 2022 Earnings Call on Friday, July 29, 2022
- RADNOR, Pa. , June 30, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its financial results for the second quarter 2022 after the market closes on July 28, 2022, and will hold a conference call on July 29, 2022, at 8:00 a.m.
- 06/30/2022
|
AVTR vs. DOCS: Which Stock Is the Better Value Option?
- AVTR vs. DOCS: Which Stock Is the Better Value Option?
- 06/29/2022
|
Avantor® to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference
- RADNOR, Pa. , June 1, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verde, Calif.
- 06/01/2022
|
Avantor: Narrowing The Relative Valuation Gap
- Avantor's pricing power has allowed it to outpace the inflationary headwinds. Cash flow remains strong, and thus, the balance sheet deleveraging is on track, allowing for future M&A optionality.
- 05/20/2022
|
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q1 2022 Results - Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR ) Q1 2022 Results Conference Call April 29, 2022 7:30 AM ET Company Participants Tommy Thomas - Vice President, Investor Relations Michael Stubblefield - President and CEO Tom Szlosek - Executive Vice President and CFO Conference Call Participants Derik De Bruin - Bank of America Vijay Kumar - Evercore Dan Brennan - Cowen Jack Meehan - Nephron Research Tejas Savant - Morgan Stanley Matt Sykes - Goldman Sachs Patrick Donnelly - Citi Paul Knight - KeyBanc Capital Markets Operator Good morning. My name is Katie, and I will be your conference operator today.
- 04/29/2022
|
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Surpass Estimates
- Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 8.57% and 0.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/28/2022
|
AVTR vs. PGNY: Which Stock Is the Better Value Option?
- AVTR vs. PGNY: Which Stock Is the Better Value Option?
- 04/11/2022
|
Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022
- RADNOR, Pa. , April 6, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its financial results for the first quarter 2022 after the market closes on April 28, 2022, and will hold a conference call on April 29, 2022, at 7:30 a.m.
- 04/06/2022
|
Avantor: Recurrent Revenue And M&A Could Push The Stock Price Up
- Avantor sells products and services to the biopharma, healthcare, education, government, and advanced technologies & applied materials industries.
- 03/03/2022
|
Avantor, Inc.'s (AVTR) CEO Michael Stubblefield on Q4 2021 Results - Earnings Call Transcript
- Avantor, Inc.'s (AVTR) CEO Michael Stubblefield on Q4 2021 Results - Earnings Call Transcript
- 02/04/2022
|
Avantor, Inc. (AVTR) Q4 Earnings and Revenues Top Estimates
- Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 9.09% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/03/2022
|
Avantor® to Report Fourth Quarter and Full Year 2021 Results and Host Earnings Call on February 4, 2022
- RADNOR, Pa., Jan. 18, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its financial results for the fourth quarter and full year 2021 after the market closes on February 3, 2022, and will hold a conference call on February 4 at 7:30 a.m.
- 01/18/2022
|
Avantor, Inc. (AVTR) Gains As Market Dips: What You Should Know
- In the latest trading session, Avantor, Inc. (AVTR) closed at $42.01, marking a +0.65% move from the previous day.
- 12/30/2021
|
Avantor, Inc. (AVTR) Gains But Lags Market: What You Should Know
- Avantor, Inc. (AVTR) closed at $41.10 in the latest trading session, marking a +0.37% move from the prior day.
- 12/22/2021
|
Avantor (AVTR) to Improve Biopharma Supply Chain With New Site
- Avantor's (AVTR) new logistics hub in Westminster is intended to support growth of single-use businesses.
- 12/20/2021
|
Avantor, Inc. (AVTR) Stock Moves -0.58%: What You Should Know
- Avantor, Inc. (AVTR) closed the most recent trading day at $39.52, moving -0.58% from the previous trading session.
- 12/16/2021
|
Avantor Stock: Growth At A Reasonable Price
- Avantor is a fascinating way to play the broader science industry due to its vast portfolio of offerings. Recent performance by Avantor has been appealing, with revenue and cash flows rising while losses turn to profits.
- 12/16/2021
|
Avantor, Inc. (AVTR) Crossed Above the 50-Day Moving Average: What That Means for Investors
- When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
- 11/23/2021
|
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q3 2021 Results - Earnings Call Transcript
- Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q3 2021 Results - Earnings Call Transcript
- 10/29/2021
|
Avantor, Inc. (AVTR) Beats Q3 Earnings and Revenue Estimates
- Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 9.38% and 0.59%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2021
|
Avantor® Announces Offering of Senior Notes
- RADNOR, Pa., Oct. 19, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the commencement of a private offering of senior notes (the "Notes") to be issued by its wholly-owned subsidiary, Avantor Funding, Inc. (the "Issuer").
- 10/19/2021
|
Down 12.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Avantor, Inc. (AVTR)
- The heavy selling pressure might have exhausted for Avantor, Inc. (AVTR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 10/14/2021
|
Avantor® Announces Preliminary Third Quarter Unaudited Revenues
- RADNOR, Pa., Oct. 12, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenue estimates for the third quarter ended September 30, 2021, in conjunction with proposed Masterflex® debt financing transactions.
- 10/12/2021
|
Avantor® to Report Third Quarter 2021 Earnings and Host Earnings Call on Friday, October 29, 2021
- RADNOR, Pa., Sept. 28, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the third quarter 2021 after the market closes on Thursday, October 28, 2021, and will hold a conference call on Friday, October 29, 2021 to discuss the results at 7:30 a.m.
- 09/28/2021
|
Top 5 High-Flying Stocks That Have Survived September Mayhem
- We have narrowed down our search to five large-cap stocks that have gained nearly 5% or more than 5% month to date. These are: AVTR, PWR, ON, KLAC, and MRNA.
- 09/22/2021
|
New Strong Buy Stocks for September 16th
- BBY, GES, MEOH, WWW, and AVTR have been added to the Zacks Rank #1 (Strong Buy) List on September 16, 2021.
- 09/16/2021
|
Avantor® Announces Pricing of Common Stock Offering
- RADNOR, Pa., Sept. 13, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor," "we" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced the pricing of the previously announced underwritten offering by the Company of 20,833,334 shares of its common stock pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"), at the public offering price of $42.00 per share.
- 09/13/2021
|
Avantor® Announces Offering of Common Stock
- RADNOR, Pa., Sept. 13, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor," "we" or the "Company"), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that the Company intends to offer for sale in an underwritten offering $750 million of its common stock pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission (the "SEC").
- 09/13/2021
|
Avantor: Life Science Giant In The Making
- Avantor: Life Science Giant In The Making
- 09/13/2021
|
Avantor to buy Masterflex for $2.7 billion in cash
- Avantor Inc. AVTR, +0.12% announced Tuesday an agreement to buy Materflex, a maker of perstaltic pumps and aseptic single-use fluid transfer technologies, in an all-cash deal valued at $2.7 billion. Avantor's stock is still inactive in premarket trading.
- 09/07/2021
|
Avantor® to Acquire Masterflex®; Expands Proprietary Single-Use Offering for Bioproduction
- RADNOR, Pa., Sept. 7, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that it has entered into a definitive agreement to acquire the Masterflex bioprocessing business and related assets (collectively "Masterflex") of Antylia Scientific, a privately held, portfolio company of investment firms GTCR and Golden Gate Capital.
- 09/07/2021
|
Avantor® Announces Investment in Hydration Capabilities to Address Growing Demand for Biologics
- RADNOR, Pa., Aug. 31, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today a multi-year investment in its global hydration capabilities.
- 08/31/2021
|
Avantor® to Host Virtual Investor Day
- RADNOR, Pa., Aug. 30, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will host a virtual investor day on September 9, 2021 starting at 9:00 a.m.
- 08/30/2021
|
Monday Afternoon Analyst Upgrades and Downgrades: CrowdStrike, EQT, Magnolia Oil and More
- The markets were higher across the board midday on Monday, with both the S&P 500 and the Nasdaq printing fresh all-time intraday highs.
- 08/30/2021
|
Avantor's (AVTR) CEO Michael Stubblefield on Q2 2021 Results - Earnings Call Transcript
- Avantor's (AVTR) CEO Michael Stubblefield on Q2 2021 Results - Earnings Call Transcript
- 07/30/2021
|
Avantor, Inc. (AVTR) Q2 Earnings and Revenues Top Estimates
- Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 16.67% and 7.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/29/2021
|
Avantor, Inc. (AVTR) Hits Fresh High: Is There Still Room to Run?
- Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 07/26/2021
|
Avantor® Publishes Inaugural Sustainability Report; Drives Positive Impact through Science for Goodness Platform
- RADNOR, Pa., July 22, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today published its first sustainability report.
- 07/22/2021
|
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
- RADNOR, Pa., July 20, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on August 16, 2021 to holders of record on August 1, 2021.
- 07/20/2021
|
Avantor® Announces Date Change for Second Quarter 2021 Earnings Release and Conference Call
- RADNOR, Pa., July 16, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it has changed the date of its previously announced earnings release and conference call.
- 07/16/2021
|
Avantor: Diversified Portfolio Mix Continues To Deliver Upside
- Avantor continues its climb on the charts, posting a 100% single-year return. The company offers a unique value proposition for low-gamma seekers or those seeking low-volatility inclusions into portfolios.
- 07/14/2021
|
Avantor® to Report Second Quarter 2021 Earnings and Host Earnings Call on Wednesday, July 28, 2021
- RADNOR, Pa., July 6, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its financial results for the second quarter 2021 after the market closes on Wednesday, July 28, 2021, and will hold a conference call on the same day to discuss the results at 5:00 p.m.
- 07/06/2021
|
Here's Why Momentum Investors Will Love Avantor, Inc. (AVTR)
- Does Avantor, Inc. (AVTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 06/18/2021
|
Is Avantor (AVTR) a Great Growth Stock?
- If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Avantor (AVTR).
- 06/17/2021
|
Market Pares Losses After Sell Off On Fed Meeting; Financials, Vista Outdoor, And Avantor In Focus
- Market pares losses after Fed meeting sell off; Financials, Vista Outdoor, and Avantor in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 06/16/2021
|
Avantor® Completes Acquisition of Ritter GmbH and its Affiliates
- RADNOR, Pa., June 10, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today it has completed its previously announced acquisition of Ritter GmbH and its affiliates.
- 06/10/2021
|
Avantor® Acquires RIM Bio; Expands Bioproduction Footprint into China
- RADNOR, Pa. and SHANGHAI, June 1, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
- 06/01/2021
|
Avantor® to Present at Goldman Sachs 42nd Annual Global Healthcare Conference
- RADNOR, Pa., May 19, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021.
- 05/19/2021
|
Time to Focus on Avantor (AVTR) for Strong Earnings Growth Potential
- If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Avantor (AVTR).
- 05/18/2021
|
Top Ranked Growth Stocks to Buy for May 3rd
- Top Ranked Growth Stocks to Buy for May 3rd
- 05/03/2021
|
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q1 2021 Results - Earnings Call Transcript
- Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q1 2021 Results - Earnings Call Transcript
- 04/30/2021
|
Avantor® Reports First Quarter 2021 Results
- RADNOR, Pa., April 28, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the first quarter ended March 31, 2021.
- 04/28/2021
|
Avantor, Inc.: Portfolio Mix Hedges Top Line, Offers Unique Value Proposition
- Avantor, Inc. continues to present a compelling investment case, with industry drivers and portfolio insulators tied into the debate.
- 04/28/2021
|
5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
- 5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
- 04/28/2021
|
Avantor® to Present at BofA Securities 2021 Virtual Health Care Conference
- RADNOR, Pa., April 27, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.
- 04/27/2021
|
Avantor® to Boost Global Production of Single-Use Technologies and Address Growing Biopharma Demand
- RADNOR, Pa., April 26, 2021 /PRNewswire/ -- Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it will increase global capacity for high-quality single-use technologies used in the production of biologics and vaccines.
- 04/26/2021
|
/C O R R E C T I O N -- Avantor and Financial News/
- In the news release, Avantor® Declares Dividend on Mandatory Convertible Preferred Stock, issued 21-Apr-2021 by Avantor and Financial News over PR Newswire, we are advised by the company that the date at the end of the first paragraph, last sentence, should read "May 1, 2021" rather than "April 1, 2021" as originally issued inadvertently. The complete, corrected release follows: Avantor® Declares Dividend on Mandatory Convertible Preferred Stock RADNOR, Pa.
- 04/22/2021
|
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
- RADNOR, Pa., April 21, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on May 17, 2021 to holders of record on April 1, 2021.
- 04/21/2021
|
Avantor, Inc. (AVTR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/21/2021
|
Avantor (AVTR) Buying Ritter In €890 Million Deal
- Avantor Performance Materials, Inc. (NYSE: AVTR) is buying Ritter GmbH and its affiliates in an all-cash transaction with an upfront equity purchase price of approximately €890 million. These are the details.
- 04/12/2021
|
Avantor® to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows
- RADNOR, Pa. and SCHWABMÜNCHEN, Germany, April 12, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that it has entered into a definitive agreement to acquire privately held Ritter GmbH and its affiliates in an all-cash transaction with an upfront equity purchase price of approximately €890 million subject to final adjustments at closing and additional payments based on achieving future business performance milestones.
- 04/12/2021
|
Avantor® to Report First Quarter 2021 Earnings and Host Earnings Call on Wednesday, April 28, 2021
- RADNOR, Pa., March 31, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the first quarter 2021 after the market closes on Wednesday, April 28, 2021, and will hold a conference call at 5:00 p.m.
- 03/31/2021
|
Avantor® Announces Credit Rating Upgrade by Moody's Investors Services
- RADNOR, Pa., March 18, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that Moody's Investor Services upgraded its Corporate Family Rating (CFR) to 'Ba3'/Stable Outlook.
- 03/18/2021
|
NB Private Equity: Monthly NAV Update - February 2021
- THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS
- 03/12/2021
|
Avantor® to Participate at the Raymond James 42nd Annual Institutional Investor Conference
- RADNOR, Pa., Feb. 22, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Raymond...
- 02/22/2021
|
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q4 2020 Results - Earnings Call Transcript
- Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q4 2020 Results - Earnings Call Transcript
- 02/03/2021
|
5 Top-Ranked Stocks Likely to Beat Earnings Estimates
- These top-ranked stocks are likely to beat on bottom line in their next releases.
- 02/03/2021
|
Is a Surprise Coming for Avantor (AVTR) This Earnings Season?
- Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/02/2021
|
Avantor, Inc. (AVTR) Is Up 5.42% in One Week: What You Should Know
- Does Avantor, Inc. (AVTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 01/29/2021
|
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
- RADNOR, Pa., Jan. 21, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today that its Board of Directors has declared a...
- 01/21/2021
|
Avantor® Announces Preliminary Fourth Quarter Unaudited Revenues and Estimated Free Cash Flow
- RADNOR, Pa., Jan. 11, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenues and free cash flow...
- 01/11/2021
|
7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible
- The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.
- 01/05/2021
|
Analysts' Top Health Care Stocks to Buy Could Be Big 2021 Winners
- As is the case every year, the major Wall Street firms we cover here at 24/7 Wall St.
- 12/29/2020
|
How Avantor helps in the vaccine supply chain
- Michael Stubblefield, Avantor CEO and president, describes his company's role in developing various vaccines to fight the coronavirus pandemic.
- 12/21/2020
|
Avantor® Sets Science in Motion for Goodness with Donations and Grants to Community-Based Organizations
- RADNOR, Pa., Dec. 17, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, is setting science in motion for goodness by giving back to...
- 12/17/2020
|
Avantor CEO talks role in scaling up Covid-19 vaccine production
- Avantor CEO Michael Stubblefield discussed how the biopharmaceutical supplier is helping to enable development of novel technologies.
- 12/15/2020
|
3 Recent IPOs to Add to Your Watch List
- These stocks have high upside that every investor should keep an eye on.
- 12/15/2020
|
Avantor CEO on the mechanics of vaccine storage and distribution
- Michael Stubblefield, Avantor CEO, joins "Squawk on the Street" to discuss the supply chain for coronavirus vaccine distribution.
- 11/30/2020
|
Ultra-Cold Freezer Makers To Profit From Covid-19 Vaccine Rush
- Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.
- 11/21/2020
|
Avantor: Diversified Portfolio Mix Should Drive Upside From Q3 Onwards
- Avantor has had a stellar year, leveraging their diverse portfolio to retain recurring revenue over the 3rd quarter. Each segment of the portfolio remains exposed less than 3%, whilst allowing exposure to COVID-19-related tailwinds.
- 11/18/2020
|
Avantor Wants to Bring Vaccine to Market in Record Time: CEO
- Nov.18 -- Avantor President and Chief Executive Officer Michael Stubblefield discusses the company's role in the fight against the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
- 11/18/2020
|
Top 10 Stocks Billionaire Daniel Loeb Just Bought
- In this article we'll take a closer look at the Top 10 Stocks Billionaire Daniel Loeb Just Bought. If you're impatient to see the pinnacle of the list, you can skip ahead to the Top 5 Stocks Billionaire Daniel Loeb Just Bought .
- 11/16/2020
|
Avantor® Announces Pricing of Upsized Secondary Offering
- RADNOR, Pa., Nov. 5, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced the pricing of...
- 11/05/2020
|
Avantor® Announces Upsizing and Pricing of Offering of €650.0 Million of Senior First Lien Notes
- RADNOR, Pa., Oct. 30, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today the pricing of the previously...
- 10/30/2020
|
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q3 2020 Results - Earnings Call Transcript
- Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
Avantor® Announces Offering of Senior First Lien Notes
- RADNOR, Pa., Oct. 28, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today the commencement of a private...
- 10/28/2020
|
Avantor® spricht auf dem World Vaccine Congress Europe 2020 über die
Leistungsfähigkeit der Supply-Chain
- Dem Unternehmen kommt aufgrund seiner Produkte und Services eine entscheidende Rolle bei der Entwicklung eines COVID-19-Impstoffs zu.
- 10/22/2020
|
IFM Investors Pty Ltd Increases Stake in Avantor Inc (NYSE:AVTR)
- IFM Investors Pty Ltd increased its position in Avantor Inc (NYSE:AVTR) by 19.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 38,627 shares of the company’s stock after acquiring an additional 6,397 shares during the quarter. IFM Investors Pty Ltd’s holdings in Avantor were […]
- 10/21/2020
|
Boric Acid Market will Exhibit Neutral Impact During 2020-2024 | Increase in Demand from Developing Countries to Improve the Market Growth | Technavio
- The Global Boric Acid Market will grow by 264.20 th MT during 2020-2024
- 10/19/2020
|
Global Cryogenic Vials Market Size Analysis by Latest Trends 2020 | Global Industry Growth Factors, CAGR Status, Leading Key Players Update, Business Share by Regions and Forecast to 2024 | Technavio
- The Global Cryogenic Vials Market will grow by USD 42.48 mn during 2020-2024
- 10/16/2020
|
Analyzing Avantor (NYSE:AVTR) and Astrotech (NYSE:ASTC)
- Avantor (NYSE:AVTR) and Astrotech (NASDAQ:ASTC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Profitability This table compares Avantor and Astrotech’s net margins, return on equity and return on assets. Net Margins […]
- 10/12/2020
|
Two Sigma Advisers LP Has $588,000 Holdings in Avantor Inc (NYSE:AVTR)
- Two Sigma Advisers LP lifted its position in shares of Avantor Inc (NYSE:AVTR) by 73.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 34,600 shares of the company’s stock after purchasing an additional 14,700 shares during the quarter. Two Sigma Advisers LP’s holdings in […]
- 10/08/2020
|
Global Silicones Market Products and Applications Report 2020 with Profiles of 69 Companies & Industry Guide with Contact Details for 140 Companies - ResearchAndMarkets.com
|
Global Laboratory Centrifuge Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
- The Global Laboratory Centrifuge market will register an incremental spend of about $292 million, growing at a CAGR of 3.42%
- 09/30/2020
|
Single-use Bioprocessing System Market- Roadmap for Recovery from COVID-19 | Growing Product Advancements and Automation to Boost the Market Growth | Technavio
- The Global Single-use Bioprocessing System Market will grow by USD 2.91 bn during 2020-2024
- 09/25/2020
|
Molecular Microplate Readers and Washers Market 2020-2024: Forecasting Strategy to Undergo A Paradigm Shift from Crisis to New Normal during COVID-19 Pandemic | Technavio
- The Global Molecular Microplate Readers and Washers Market will grow by USD 270.80 mn during 2020-2024
- 09/24/2020
|
Avantor (NYSE:AVTR) Reaches New 1-Year High at $23.36
- Avantor Inc (NYSE:AVTR) reached a new 52-week high during trading on Wednesday . The stock traded as high as $23.36 and last traded at $22.54, with a volume of 162463 shares changing hands. The stock had previously closed at $21.76. Several research analysts have recently commented on the stock. Raymond James lifted their price target […]
- 09/18/2020
|
Spectrophotometer Market: COVID-19 Business Continuity Plan | Evolving Opportunities With Agilent Technologies Inc. and Avantor Inc. | Technavio
- The Global Spectrophotometer Market will grow by $ 869.24 mn during 2020-2024
- 09/15/2020
|
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
- Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.
- 09/11/2020
|
Tracking Dan Loeb's Third Point Portfolio - Q2 2020 Update
- Dan Loeb's 13F portfolio value increased from $6.27B to $7.30B this quarter. The number of positions increased from 30 to 36.
- 08/28/2020
|
Avantor Target of Unusually High Options Trading (NYSE:AVTR)
- Avantor Inc (NYSE:AVTR) was the target of some unusual options trading activity on Wednesday. Traders bought 2,957 put options on the stock. This is an increase of 1,871% compared to the average daily volume of 150 put options. Shares of Avantor stock opened at $21.75 on Thursday. The business has a fifty day simple moving […]
- 08/27/2020
|
Avantor Inc (NYSE:AVTR) Director Jo Natauri Sells 15,397,005 Shares
- Avantor Inc (NYSE:AVTR) Director Jo Natauri sold 15,397,005 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $19.51, for a total transaction of $300,395,567.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available […]
- 08/26/2020
|
New York State Common Retirement Fund Acquires 126,109 Shares of Avantor Inc (NYSE:AVTR)
- New York State Common Retirement Fund increased its holdings in Avantor Inc (NYSE:AVTR) by 17.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 844,953 shares of the company’s stock after buying an additional 126,109 shares during the period. New York State Common Retirement […]
- 08/26/2020
|
Analysis on Impact of COVID-19: Chromatography Resins Market 2020-2024 | Increasing R&D In Biopharmaceuticals to Boost the Market Growth | Technavio
- The Global Chromatography Resins Market will grow by USD 1.17 bn during 2020-2024
- 08/24/2020
|
Avantor® Announces Secondary Offering of 38,500,000 Shares of Common Stock
- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that certain of its stockholders (the "Selling Stockholders"), including an affiliate of New Mountain Capital, LLC, intend to offer for sale in an underwritten secondary offering 38,500,000 shares of common stock of the Company pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The Selling Stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 5,775,000 shares of common stock on the same terms and conditions. No shares are being sold by the Company. The Selling Stockholders will receive all of the proceeds from this offering.
- 08/19/2020
|
Avantor Announces Credit Rating Upgrade by S&P Global Ratings
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that S&P Global Ratings upgraded its long-term issuer default rating (IDR) to 'BB-'/Positive Outlook.
- 08/10/2020
|
56,394 Shares in Avantor Inc (NYSE:AVTR) Bought by Zurcher Kantonalbank Zurich Cantonalbank
- Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Avantor Inc (NYSE:AVTR) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 56,394 shares of the company’s stock, valued at approximately $959,000. A number of other institutional investors have also recently […]
- 08/10/2020
|
FY2021 EPS Estimates for Avantor Inc (NYSE:AVTR) Raised by Truist Securiti
- Avantor Inc (NYSE:AVTR) – Research analysts at Truist Securiti upped their FY2021 EPS estimates for shares of Avantor in a research note issued to investors on Tuesday, August 4th. Truist Securiti analyst S. Draper now anticipates that the company will earn $0.98 per share for the year, up from their previous estimate of $0.97. Truist […]
- 08/09/2020
|
Insights on the Global Alcohol Prep Pads Market 2020-2024 | COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio
- The Global Alcohol Prep Pads Market will grow by USD 160.61 mn during 2020-2024
- 08/07/2020
|
Sumitomo Mitsui Trust Holdings Inc. Takes Position in Avantor Inc (NYSE:AVTR)
- Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Avantor Inc (NYSE:AVTR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,665,389 shares of the company’s stock, valued at approximately $28,312,000. Several other hedge funds and other institutional investors […]
- 08/04/2020
|
63,129 Shares in Avantor Inc (NYSE:AVTR) Acquired by Strs Ohio
- Strs Ohio acquired a new stake in Avantor Inc (NYSE:AVTR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 63,129 shares of the company’s stock, valued at approximately $1,073,000. A number of other large investors have also recently modified their holdings […]
- 08/03/2020
|
Advisor Group Holdings Inc. Makes New Investment in Avantor Inc (NYSE:AVTR)
- Advisor Group Holdings Inc. purchased a new position in Avantor Inc (NYSE:AVTR) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,328 shares of the company’s stock, valued at approximately $54,000. A number of other institutional investors and hedge […]
- 08/03/2020
|
Nissay Asset Management Corp Japan ADV Purchases New Shares in Avantor Inc (NYSE:AVTR)
- Nissay Asset Management Corp Japan ADV acquired a new position in shares of Avantor Inc (NYSE:AVTR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 45,382 shares of the company’s stock, valued at approximately $771,000. Other institutional investors and […]
- 08/03/2020
|
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q2 2020 Results - Earnings Call Transcript
- Avantor, Inc. (NYSE:AVTR) Q2 2020 Earnings Conference Call July 29, 2020, 05:00 PM ET Company Participants Tommy Thomas - VP, IR Michael Stubblefield - President and CEO Tom Szlosek - EVP and CFO Conference Call Participants Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Vijay Kumar - Evercore ISI Doug Schenkel - Cowen Jack Meehan - Nephron Research Patrick Donnelly - Citi Brandon Couillard - Jefferies Dan Brennan - UBS Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Avantor's Second Quarter 2020 Earnings Conference Call.
- 07/30/2020
|
What Kind Of Investors Own Most Of Avantor, Inc. (NYSE:AVTR)?
- Every investor in Avantor, Inc. (NYSE:AVTR) should be aware of the most powerful shareholder groups. Generally...
- 07/30/2020
|
Avantor, Inc. 2020 Q2 - Results - Earnings Call Presentation
- The following slide deck was published by Avantor, Inc. in conjunction with their 2020 Q2 earnings call..
- 07/30/2020
|
AVANTOR (AVTR) Q2 2020 Earnings Call Transcript
- AVTR earnings call for the period ending June 30, 2020.
- 07/30/2020
|
Avantor, Inc. (AVTR) Beats Q2 Earnings Estimates
- Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 35.71% and -0.53%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/29/2020
|
Avantor: Q2 Earnings Insights
- Shares of Avantor (NYSE:AVTR) rose 3.64% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 35.71% year over year to $0.19, which beat the estimate of $0.14.Revenue of $1,479,000,000 declined by 3.46% year over year, which beat the estimate of $1,450,000,000.Guidance Earnings guidance hasn't been issued by the company for now.Avantor hasn't issued any revenue guidance for the time being.How To Listen To The Conference Call Date: Jul 29, 2020View more earnings on AVTRTime: 05:00 PMET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.avantorsciences.com%2Finvestors%2Fevents-and-presentations%2Fdefault.aspx&eventid=2399364&sessionid=1&key=BC38D321EB28CBD6C8C92019E8DB7967®Tag=&sourcepage=registerPrice Action Company's 52-week high was at $19.75Company's 52-week low was at $6.66Price action over last quarter: Up 17.67%Company Overview Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.See more from Benzinga * Conmed: Q2 Earnings Insights * Knowles: Q2 Earnings Insights * Cognizant Tech Solns: Q2 Earnings Insights(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 07/29/2020
|
Why Earnings Season Could Be Great for Avantor (AVTR)
- Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 07/28/2020
|
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Avantor, Inc. (AVTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/22/2020
|
Redpoint Investment Management Pty Ltd Purchases New Holdings in Avantor Inc (NYSE:AVTR)
- Redpoint Investment Management Pty Ltd acquired a new position in Avantor Inc (NYSE:AVTR) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 18,821 shares of the company’s stock, valued at approximately $320,000. Other large investors have also recently made changes to their positions in the […]
- 07/22/2020
|
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on August 15, 2020 to holders of record on August 1, 2020.
- 07/21/2020
|
$473 Million Worldwide Aseptic Sampling Industry to 2025 - Featuring Danaher, Saint-Gobain & GEA Group Among Others - ResearchAndMarkets.com
|
IFM Investors Pty Ltd Invests $548,000 in Avantor Inc (NYSE:AVTR)
- IFM Investors Pty Ltd purchased a new position in Avantor Inc (NYSE:AVTR) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 32,230 shares of the company’s stock, valued at approximately $548,000. Several other institutional investors have also recently made changes to […]
- 07/19/2020
|
Why the Earnings Surprise Streak Could Continue for Avantor, Inc. (AVTR)
- Avantor, Inc. (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/15/2020
|
48,700 Shares in Avantor Inc (NYSE:AVTR) Purchased by DNB Asset Management AS
- DNB Asset Management AS acquired a new position in shares of Avantor Inc (NYSE:AVTR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 48,700 shares of the company’s stock, valued at approximately $828,000. Other institutional investors and hedge funds have […]
- 07/14/2020
|
Insights on the Global Boric Acid Market 2020-2024 | COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats | Technavio
- The Global Boric Acid Market will grow by 264.20 th MT during 2020-2024
- 07/14/2020
|
Did Hedge Funds Make The Right Call On Avantor, Inc. (AVTR) ?
- Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
- 07/11/2020
|
ClearBridge Mid Cap Strategy Portfolio Manager Commentary Q2 2020
- ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers.
- 07/11/2020
|
Avantor® Announces Upsizing and Pricing of Offering of $2.0 Billion Equivalent of Senior Notes
- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the pricing of the previously announced private offering by its wholly-owned subsidiary, Avantor Funding, Inc. (the "Issuer"), of $1.550 billion aggregate principal amount of 4.625% Senior Notes due 2028 and €400 million aggregate principal amount of 3.875% Senior Notes due 2028 (collectively, the "Notes"). The principal amount of the dollar-denominated notes has been upsized from the $1.0 billion previously announced. The Notes will mature on July 15, 2028. The offering is expected to close on July 17, 2020, subject to customary closing conditions.
- 07/07/2020
|
Avantor® Announces Preliminary Second Quarter 2020 Unaudited Revenue
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenue estimates for the quarter ended June 30, 2020, in conjunction with a separately announced proposed offering of debt securities. Avantor also plans to increase its revolving credit facility and extend its maturity date.
- 07/07/2020
|
Avantor® Announces Offering of Senior Notes
- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the commencement of a private offering of dollar-denominated and euro-denominated senior notes (the "Notes") to be issued by its wholly-owned subsidiary, Avantor Funding, Inc. (the "Issuer"). The Notes will be guaranteed on a joint and several basis by Vail Holdco Sub LLC, the Issuer's direct parent and a direct wholly-owned subsidiary of Avantor ("Holdco"), and by each of Holdco's wholly-owned domestic subsidiaries that guarantees obligations under the Issuer's senior secured credit facilities.
- 07/07/2020
|
Avantor® to Report Second Quarter Earnings and Host Earnings Call on Wednesday, July 29, 2020
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the second quarter 2020 after the market closes on Wednesday, July 29, 2020, and will hold a conference call on the same day to discuss the results at 5:00 pm EDT.
- 07/01/2020
|
Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced the expansion of the company's Bridgewater, N.J. (USA) innovation center. Located close to biotech companies, the site now has nearly double the laboratory and support space.
- 06/30/2020
|
Avantor® Named to Fortune 500 List
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced its first inclusion in the Fortune 500 list, ranking 484 on the list of the largest U.S. companies by revenue.
- 06/23/2020
|
Maverick Capital Ltd. Buys 1,980,755 Shares of Avantor Inc (NYSE:AVTR)
- Maverick Capital Ltd. grew its stake in shares of Avantor Inc (NYSE:AVTR) by 54.4% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,625,123 shares of the company’s stock after acquiring an additional 1,980,755 shares during the period. Avantor comprises 1.5% of Maverick Capital Ltd.’s […]
- 06/23/2020
|
Principal Financial Group Inc. Has $1.62 Million Stock Holdings in Avantor Inc (NYSE:AVTR)
- Principal Financial Group Inc. lifted its holdings in shares of Avantor Inc (NYSE:AVTR) by 12.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 129,662 shares of the company’s stock after buying an additional 14,727 shares during the period. Principal Financial […]
- 06/20/2020
|
Avantor Target of Unusually High Options Trading (NYSE:AVTR)
- Avantor Inc (NYSE:AVTR) was the target of some unusual options trading on Wednesday. Investors acquired 5,388 call options on the stock. This is an increase of approximately 1,183% compared to the average daily volume of 420 call options. Shares of AVTR stock opened at $17.68 on Friday. Avantor has a twelve month low of $6.66 […]
- 06/19/2020
|
Assessment of COVID-19's Effect on Cryogenic Vials Market 2020-2024 | Growing Adoption of Barcoded Cryogenic Vials to Augment Growth | Technavio
- The Global Cryogenic Vials Market will grow by USD 42.48 mn during 2020-2024
- 06/19/2020
|
Assessment of COVID-19's Effect on Laboratory Mixer Market 2020-2024 | Awareness About Laboratory Equipment to Augment Growth | Technavio
|
Assessment of COVID-19's Effect on Laboratory Mixer Market 2020-2024 | Awareness About Laboratory Equipment to Augment Growth | Technavio
- The Global Laboratory Mixer Market will grow by USD 281.24 mn during 2020-2024
- 06/18/2020
|
Avantor Inc (NYSE:AVTR) Expected to Post Quarterly Sales of $1.44 Billion
- Brokerages expect Avantor Inc (NYSE:AVTR) to announce $1.44 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have issued estimates for Avantor’s earnings, with the highest sales estimate coming in at $1.49 billion and the lowest estimate coming in at $1.37 billion. Avantor posted sales of $1.53 billion during the […]
- 06/17/2020
|
COVID-19 Impact and Recovery Analysis | Laboratory Centrifuge Procurement Intelligence Report Forecasts Spend Growth of over USD 292 Billion
- The global Laboratory Centrifuge Procurement Intelligence Report Forecasts Spend Growth of over USD 292 billion between 2020-2024
- 06/12/2020
|
Why I Stopped Saying 'Overvalued' And 'Undervalued': A More Insightful Approach To Valuation
- This article is a 101-level introduction to valuation, detailing why I prefer thinking about stocks as yield-producing assets. Within this frame, I explain the
- 06/10/2020
|
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2020 Update
- Halvorsen's 13F portfolio value decreased from $21.35B to $19.21B. The number of positions decreased from 66 to 64. Viking Global increased Comcast, Fidelity Na
- 06/08/2020
|
Do Hedge Funds Love Avantor, Inc. (AVTR)?
- The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]
- 06/08/2020
|
Enzyme-Linked Immunosorbent Assay (ELISA) Market 2020-2024 | Increasing Incidences of Cancer to Boost Growth | Technavio
- The Global Enzyme-linked Immunosorbent Assay (ELISA) Market will grow by USD 124.55 mn during 2020-2024
- 06/01/2020
|
8 Stocks Viking Global Investors Continues to Buy
- Visa and Cigna make the list Continue reading...
- 05/29/2020
|
Single-use Bioprocessing System Market 2020-2024 | Growing Product Advancements and Automation to Boost Growth | Technavio
- The Global Single-use Bioprocessing System Market will grow by USD 2.91 bn during 2020-2024
- 05/29/2020
|
Avantor® Announces Closing of Secondary Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced the closing of the previously announced underwritten secondary offering of 51,750,000 shares of the Company's common stock held by certain of its stockholders (the "Selling Stockholders") at the public offering price of $16.25 per share, including the full exercise by the underwriters of their option to purchase up to 6,750,000 additional shares of common stock.
- 05/26/2020
|
7 Stocks Maverick Capital Continues to Buy
- Adobe and Avantor make the list Continue reading...
- 05/26/2020
|
Avantor (AVTR) Catches Eye: Stock Jumps 7.8%
- Avantor (AVTR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
- 05/26/2020
|
Avantor Announces Credit Rating Upgrade by Fitch Ratings
- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that Fitch Ratings upgraded its long-term issuer default rating (IDR) to 'BB-'/Stable Outlook.
- 05/22/2020
|
Avantor® Announces Pricing of Secondary Offering
- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced the pricing of the previously announced underwritten secondary offering of 45,000,000 shares of the Company's common stock (the "Offering") held by certain of its stockholders (the "Selling Stockholders") pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"), at the public offering price of $16.25 per share.
- 05/21/2020
|
Avantor® Announces Secondary Offering of 45,000,000 Shares of Common Stock
- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that certain of its stockholders (the "Selling Stockholders") intend to offer for sale in an underwritten secondary offering 45,000,000 shares of common stock of the Company pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The Selling Stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 6,750,000 shares of common stock on the same terms and conditions. No shares are being sold by the Company. The Selling Stockholders will receive all of the proceeds from this offering.
- 05/18/2020
|
Investors Who Bought Avantor (NYSE:AVTR) Shares A Year Ago Are Now Up 22%
- These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors...
- 05/15/2020
|
Avantor to Present at the Virtual Bank of America Securities 2020 Healthcare Conference
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in the Bank of America Securities 2020 Healthcare Conference, taking place virtually on Tuesday, May 12. Avantor's presentation is scheduled to begin at approximately 1:40 p.m. Eastern time.
- 05/06/2020
|
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
- Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
- 05/06/2020
|
Avantor Sees Unusually High Options Volume (NYSE:AVTR)
- Avantor Inc (NYSE:AVTR) was the recipient of unusually large options trading activity on Wednesday. Investors bought 1,243 call options on the stock. This represents an increase of 981% compared to the typical daily volume of 115 call options. NYSE:AVTR opened at $16.81 on Friday. Avantor has a 1-year low of $6.66 and a 1-year high […]
- 05/01/2020
|
Why Avantor Stock Popped 14% Today
- Shares of chemicals-maker Avantor (NYSE: AVTR) closed 14.4% higher Thursday after reporting Q1 2020 earnings results that exceeded analyst expectations for both sales and earnings. Analysts had forecast Avantor would earn $0.15 per share on $1.47 billion in sales. In fact, Avantor earned $0.17 per share on sales of $1.52 billion.
- 05/01/2020
|
Avantor Q1 2020 Earnings: Thesis Intact And Risks Mitigated
- Avantor posted a strong Q1 2020, beating consensus revenue, EBITDA, EPS, and FCF. Academic labs, equipment, and certain industrial areas were weak as I expected
- 04/30/2020
|
Credit Suisse Gives a Buy Rating to Avantor (AVTR)
- In a report released yesterday, Erin Wright from Credit Suisse assigned a Buy rating to Avantor (AVTR), with a price target of $18.00. The company's
- 04/30/2020
|
Credit Suisse Gives a Buy Rating to Avantor (AVTR)
- In a report released yesterday, Erin Wright from Credit Suisse assigned a Buy rating to Avantor (AVTR – Research Report),
- 04/30/2020
|
Analysts Conflicted on These Conglomerates Names: Masco (MAS), Avantor (AVTR) and O-I Glass (OI)
- Analysts have been eager to weigh in on the Conglomerates sector with new ratings on Masco (MAS), Avantor (AVTR) and O-I Glass (OI). Masco (MAS) In a
- 04/30/2020
|
Avantor (AVTR) Q1 2020 Earnings Call Transcript
- Image source: The Motley Fool. Avantor (NYSE: AVTR)Q1 2020 Earnings CallApr 29, 2020, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon.
- 04/30/2020
|
Avantor Reports First Quarter 2020 Results
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the first quarter ended March 31, 2020.
- 04/29/2020
|
Healthcare Stock Q1 Earnings Due on Apr 29: ANTM, HUM, AVTR
- Higher premiums and share buyback might have driven earnings for healthcare stocks in the first quarter of 2020.
- 04/28/2020
|
Healthcare Stock Q1 Earnings Due on Apr 29: ANTM, HUM, AVTR
- Higher premiums and share buyback might have driven earnings for healthcare stocks in the first quarter of 2020.
- 04/28/2020
|
Analysts Offer Insights on Conglomerates Companies: Ardagh Group SA (ARD), Veoneer (VNE) and Avantor (AVTR)
- Companies in the Conglomerates sector have received a lot of coverage today as analysts weigh in on Ardagh Group SA (ARD), Veoneer (VNE) and Avantor
- 04/27/2020
|
Avantor® and the Avantor Foundation Provide Support to Address Coronavirus (COVID-19) Pandemic
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies & applied materials industries, and the Avantor Foundation, a private charitable foundation funded by Avantor, approved a humanitarian relief donation to Charities Aid Foundation of America (CAF America) to help organizations around the world on the frontlines addressing the coronavirus (COVID-19) pandemic.
- 04/23/2020
|
Avantor® Declares Dividend on Mandatory Convertible Preferred Stock
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on May 15, 2020 to holders of record on May 1, 2020.
- 04/21/2020
|
Biological Buffers Market Size, Status Report 2020 by Manufacturers, Type and Application, Forecast to 2026
- Apr 21, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Biological Buffers Market” report...
- 04/21/2020
|
Avantor: A Little More Cautious Into Earnings
- I am more cautious on Avantor’s (AVTR) near-term fundamentals than when I first wrote about the company about a month ago. I see more risk to the ~10% of revenu
- 04/19/2020
|
Analysts Offer Insights on Conglomerates Companies: Masonite International (DOOR) and Avantor (AVTR)
- There's a lot to be optimistic about in the Conglomerates sector as 2 analysts just weighed in on Masonite International (DOOR) and Avantor (AVTR) with
- 04/08/2020
|
Bank of New York Mellon Corp Raises Holdings in Avantor Inc (NYSE:AVTR)
- Bank of New York Mellon Corp boosted its stake in shares of Avantor Inc (NYSE:AVTR) by 8.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 919,293 shares of the company’s stock after buying an additional 67,802 shares during the […]
- 04/08/2020
|
Avantor® to Report First Quarter 2020 Earnings and Host Earnings Call on Wednesday, April 29, 2020
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life science and advanced technologies & applied materials industries, announced today that it will release its financial results for the first quarter 2020 after the market closes on Wednesday, April 29, 2020, and will hold a conference call on the same day to discuss the results at 5:00 pm EDT.
- 04/03/2020
|
Avantor (AVTR) Gets a Buy Rating from Barclays
- In a report released today, Jack Meehan from Barclays maintained a Buy rating on Avantor (AVTR), with a price target of $19.00. The company's shares
- 03/26/2020
|
Hedge Funds Were Getting Burned By Avantor, Inc. (AVTR) Before The Coronavirus
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 03/23/2020
|
Analytical Instruments for Drug Screening Market Share And Size 2020-2023: Covering Recent Trend and Future Growth, Feasibility, Regional Outlook and Future Forecast
- Mar 23, 2020 (The Expresswire) --
Final Report will add the analysis of the impact of COVID-19 on this industry Global “Analytical Instruments for Drug...
- 03/23/2020
|
Avantor Appoints Tommy Thomas as Vice President, Investor Relations
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced Tommy Thomas has joined the Company as Vice President, Investor Relations. He will report to Thomas
- 03/23/2020
|
Varied Analyst Comments On Avantor, Inc.(AVTR) , Healthcare Services Group, Inc.(HCSG) | Post Analyst
- Shares of Avantor, Inc. (AVTR) have traded between $6.66 – 19.59. The next earnings date is set for May 01, 2020. Let’s see how its prospects are shaping up. What does Avantor, Inc.(AVTR) do? Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and …
- 03/20/2020
|
Hedge Funds Started Selling CF Industries Holdings, Inc. (CF) Before The Coronavirus
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 03/19/2020
|
Hedge Funds Aren’t Done Buying Pinterest, Inc. (PINS)
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 03/19/2020
|
Hedge Funds Have Never Been This Bullish On NiSource Inc. (NI)
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 03/19/2020
|
Hedge Funds Have Never Been This Bullish On Trimble Inc. (TRMB)
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 03/19/2020
|
Avantor® Launches New Protein A Chromatography Resin - PROchievA - that Provides Supply Chain Flexibility and Improves Downstream Purification Performance for Monoclonal Antibodies (mAbs) Production
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAbs production.
- 03/18/2020
|
Biological Safety Cabinets and Clean Benches Market Trend And Forecast Report 2020 Emphases on Key Players, Research Methodology, Profit, Capacity, Production and Forecast 2023
- Mar 18, 2020 (The Expresswire) --
Global “Biological Safety Cabinets and Clean Benches Market” Report 2020 is a comprehensive, professional report provides a...
- 03/18/2020
|
JPMorgan continues to recommend select exposure to Life Science Tools DHR;AVTR;PPD;IQV;CTLT;ADPT;GH;NSTG;TXG
- JPMorgan continues to recommend select exposure to Life Science Tools JPMorgan DHR AVTR PPD IQV CTLT ADPT GH NSTG TXG
- 03/11/2020
|
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2019 Update
- Halvorsen's 13F portfolio value increased from $19.20B to $21.35B. The number of positions increased from 61 to 66. Viking Global increased Uber Technologies wh
- 03/08/2020
|
8 2019 IPO Stocks To Buy, Sell Or Hold
- Overall, 2019 was a huge year for the stock market, and there were plenty of high-profile IPOs throughout the year as well. Unfortunately, some of the most eagerly anticipated IPOs of the past year ended up being flops for investors.But now that the excitement and volatility associated with 2019 IPOs has died down, investors can get a clearer look at the fundamentals, valuation and potential long-term upside of these stocks. The 2019 IPO class was a mixed bag in 2019, and it's still that way heading into 2020.Here are eight 2019 IPO stocks to buy, sell and hold.LYFT Inc (NASDAQ: LYFT) - Buy Lyft may have been the highest profile IPO flop of 2019, and its stock is still trading well below its $72 per share IPO price in April of last year. Despite the disappointment, CFRA analyst Angelo Zino recently said long-term investors should step in and buy the dip.Lyft has struggled with profitability, but Zino said the stock should benefit from a massive end market, a scalable and recurring revenue-driven business model and an opportunity for sizable margin expansion. Zino said Lyft is still gaining market share in a rapidly growing ridesharing industry and is making the right moves toward cutting costs and achieving profitability.CFRA has a Buy rating and $70 price target for LYFT stock.Uber Technologies Inc (NYSE: UBER) - Buy Uber is off to a hot start to 2020 after a disappointing 2019. The ridesharing stock soared in January and February after an impressive earnings report. Uber management also said the company will achieve profitability by the end of 2020.Uber and Lyft are dealing with uncertainties surrounding California's AB5 law, which could significantly increase costs in the near-term. But Bank of America analyst Justin Post recently said the long-term outlook for Uber is bright given its massive addressable market, its technology leadership in autonomous vehicles, and secular shifts toward a sharing economy.Bank of America has a Buy rating and $49 price target for UBER stock.See Also: Whitney Tilson: 'I Think We Are In An IPO Bubble'Pinterest Inc (NYSE: PINS) - Hold Unlike Uber and Lyft, Pinterest shares are actually trading slightly above their 2019 IPO price, but they've still underperformed the broad market and been a disappointment to investors.Following a fourth-quarter earnings beat, Post said Pinterest demonstrated better convergence optimization and reported impressive growth in international users and average revenue per user. In addition, the company's 2020 guidance was mostly in-line with expectations. Post said international ARPU is still just 5% of the U.S. rate, suggesting plenty of opportunity for upside.Bank of America has a Neutral rating and $32 price target for PINS stock.Avantor Inc (NYSE: AVTR) - Buy Avantor didn't get as many headlines as some of the other big IPOs of 2019, but the chemical company raised $3.33 billion in its May 2019 IPO.Following its recent earnings report, Bank of America analyst Derik de Bruin said the stock's negative initial reaction was overdone and Avantor's 2020 outlook is solid. Looking ahead, de Bruin said the challenge for the company will be to balance deleveraging its balance sheet with pursuing expansion opportunities and developing proprietary products. For now, de Bruin said Avantor's valuation is attractive relative to peers given its growth numbers.Bank of America has a Buy rating and $21 price target for AVTR stock.XP Inc (NASDAQ: XP) - Hold Brazilian independent investment platform XP is off to a strong start on the market after its December IPO. However, after the company reported preliminary first-quarter numbers in January, Bank of America analyst Mario Pierry said the stock has plenty of additional upside ahead.XP reported 1.7 million retail clients as of the end of 2019, up about 90% from a year ago. Year-end assets under custody were up more than 100% from a year ago and ahead of Pierry's estimate. While these numbers suggest a strong growth story for XP moving forward, Pierry said the stock is fairly valued following its initial post-IPO run.Bank of America has a Neutral rating and $43 price target for XP stock.SmileDirectClub Inc (NASDAQ: SDC) - Buy SmileDirectClub is the market leader in direct-to-consumer orthodontics. The stock hit the market at an IPO price of $23 per share back in September and was one of the biggest high-profile lops of the year. Shares are now trading at just $7.92, but Bank of America analyst Michael Ryskin recently said there is value in SmileDirectClub for patient investors that are willing to ride out the company's growing pains.SmileDirectClub reported fourth-quarter aligner case shipments and revenue below consensus expectations, but Ryskin said the stock still has the potential to be one of the best growth plays in the healthcare sector.Bank of America has a Buy rating and $12 price target for SDC stock.Tradeweb Markets Inc (NASDAQ: TW) - Buy Tradeweb is a trading platform provider for more that 2,500 clients, and the stock has been a huge winner since its April IPO at $17 per share.Bank of America analyst Michael Carrier recently said Tradeweb's combination of structural growth, solid operating leverage and robust cash flow will be a winning recipe for investors. Carrier said Tradeweb's 32% volume growth in 2019 is especially impressive given most of its peers saw flat volume growth on the year.Bank of America has a Buy rating and $53 price target for TW stock.SciPlay Corp (NASDAQ: SCPL) - Sell SciPlay develops and produces social mobile and web casino games. Investors that took a gamble on the company's $16 IPO back in May 2019 have seen their bankrolls take a hit given the stock is now under $10.Bank of America analyst Ryan Gee recently said there wasn't much to like about the company's fourth-quarter earnings report. For three consecutive quarters SciPlay has missed Wall Street expectations, and Gee said its lack of clarity or guidance in the quarters to come is a red flag.Bank of America has an Underperform rating and $9 price target for SCPL stock.Latest Ratings for UBER DateFirmActionFromTo Mar 2020NeedhamMaintainsBuy Feb 2020KeyBancInitiates Coverage OnOverweight Feb 2020Morgan StanleyMaintainsOverweight View More Analyst Ratings for UBER View the Latest Analyst Ratings See more from Benzinga * Ark Invest Says Autonomous Ride-Hailing Now Looks Even More Profitable Than Previously Estimated * Analyst Sees 'Gap In Profitability' Emerging Between Uber, Lyft * Uber, Postmates Fail To Block California Gig Worker Law In Court(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 03/04/2020
|
Big Corporations Are Rushing Into Venture Capital. That May Not Be a Good Thing.
- Investing in start-ups is seen as a way to gain in edge in new technologies that could ensure future growth. But does the arrival of companies signal a peak in the market?
- 02/29/2020
|
Tracking Dan Loeb's Third Point Portfolio - Q4 2019 Update
- Dan Loeb's 13F portfolio value increased from $8.42B to $8.70B this quarter. The number of positions decreased from 40 to 37. Third Point added IAA, Inc. while
- 02/18/2020
|
Saudi Aramco and Alibaba made for a great 2019 in IPO market despite Uber, Lyft busts
- Saudi Aramco, Alibaba and Uber topped the list for the biggest initial public offerings of 2019. The $2 trillion Saudi Aramco IPO set a record for largest share offering.
- 12/29/2019
|
Saudi Aramco isn't the best-performing stock debut of the day. Brazilian finance firm XP skyrocketed 24% in its multibillion-dollar IPO.
- Brazilian financial services company XP Inc. surged as much as 26% Wednesday after its initial public offering raised nearly $2 billion. The stock jump establishes XP as outperforming Saudi Aramco , which soared 10% after its record-breaking IPO . XP's market debut follows a slew of IPO flops in 2019 . Uber, Peloton, and Lyft all slumped in their first days of trading, and WeWork canceled its IPO after analyst scrutiny sank the firm's valuation. Visit the Business Insider homepage for more stories . Shares of Brazilian financial services group XP Inc. spiked as much as 26% Wednesday following its initial public offering, outperforming Saudi Aramco's record-breaking debut . XP raised nearly $2 billion in its Nasdaq exchange offering after pricing shares at the top of its previously established range. The offering is the fourth-biggest hosted by the exchange this year, further solidifying its lead over the New York Stock Exchange in IPO funds raised in 2019. Uber , Avantor , and Lyft had the largest IPOs of the year, raising $8.1 billion, $3.3 billion, and $2.6 billion, respectively.
- 12/11/2019
|
Case studies: Audit tools in 2019
- Three organizations share their experiences applying different applications to auditing
- 10/16/2019
|
The long-Term Viability Of Kosmos Energy Ltd. (KOS), Avantor, Inc. (AVTR) | Post Analyst
- Volume for increased on 07/18/19 and the net result is a 0.15 gain from the open. The stock closed with a volume of 3295939 shares stronger than the 1-week average volume of 2844340 shares per day. The regular trading started at $5.54 but as the trading progressed, the stock escalated, completing the session with a …
- 07/19/2019
|
IPO Insider: Market Set for Busy Summer Following Big Quarter - Market Insights
- The initial public offerings (IPOs) are surging as a new generation of technology and health-care stocks join the market. Roughly $32.5 billion of deals priced between April and June, according to ClickIPO. That made it the most active quarter since July-September of 2015. “A large number of offerings are in registration and expected to go …
- 07/10/2019
|
